Results 91 to 100 of about 22,657 (185)

Classifications and imaging of juvenile spondyloarthritis [PDF]

, 2018
Juvenile spondyloarthritis may be present in at least 3 subtypes of juvenile idiopathic arthritis according to the classification of the International League of Associations for Rheumatology.
Eshed, Iris, Herregods, Nele, Jans, Lennart, Sudoł-Szopińska, Iwona, Teh, James, Vojinovic, Jelena   +5 more
core   +3 more sources

Spondyloarthritis Associated With Collagenous Colitis—Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Collagenous colitis (CC) is a subtype of microscopic colitis characterized by chronic watery diarrhea with normal endoscopic findings. Although often linked to autoimmune diseases, its association with spondyloarthropathy (SpA) is rare and poorly documented.
Charlotte Bouvy, Abeline Kapuczinski, Sophiane Ibrahimi, Marc Léon, Nathalie Demeulenaere   +4 more
wiley   +1 more source

Current Challenges in Managing SpA

Journal of Clinical Rheumatology and Immunology
Managing spondyloarthritis (SpA) presents several complex challenges that impact patient outcomes. One of the foremost issues is the delay in diagnosis, often due to overlapping symptoms with other conditions and insufficient awareness among clinicians ...
Georg Schett
doaj   +1 more source

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. [PDF]

, 2017
Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA).
Adrian Ciurea, Almut Scherer, Burkhard Möller, Giorgio Tamborrini, Jürg Bernhard, Lukas M. Wildi, Michael J. Nissen, Monika Hebeisen, on behalf of the Rheumatologists of the Swiss Clinical Quality Management Program, Pascal Zufferey, Pascale Exer, Raphael Micheroli   +11 more
core   +5 more sources

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 887-899, May 2026.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Targeting inflammatory pathways in axial spondyloarthritis. [PDF]

, 2019
The triggers and pathogenesis of axial spondyloarthritis (axSpA) are not yet completely understood. However, therapeutic agents targeting tumor necrosis factor-α and interleukin-17 inflammatory pathways have proven successful in suppressing many of the ...
Furst, Daniel E, Louie, James S
core  

Spondüloartriidi nüüdisaegne käsitlus [PDF]

, 2016
Spondüloartriidi käsitluses on viimase kümnendi jooksul toimunud olulised muutused, mille ajendiks on olnud vajadus diagnoosida põletikulisi seljahaigusi kiiremini ja alustada varem ravi.
Kallikorm, Riina, Ulst, Katrin
core   +2 more sources

Risk of myocardial infarction with use of selected nonsteroidal anti-inflammatory drugs in spondyloarthritis patients [PDF]

, 2017
BACKGROUND: Spondyloarthritis (SpA) is associated with increased risk of myocardial infarction (MI); the risk may be due to the underlying inflammatory disease, or also due to medications that increase MI risk, such as certain non-steroidal anti ...
Dubreuil, Maureen
core   +1 more source

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study [PDF]

, 2017
AIM To report adalimumab (Ada) efficacy on articulargastrointestinal disease and health-related quality of life (HRQoL) in patients with enteropathic spondyloarthritis (ES).
Benfaremo, D., Bolognini, L., Ciccia, F., Ciferri, M., Farinelli, A., Gabrielli, A., Luchetti, M., Mosca, P., Rossini, M., Triolo, G.   +9 more
core   +1 more source

Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis

RMD Open, 2019
Objective Spondyloarthritis (SpA) can encompass axial, peripheral and extra-articular disease manifestations. Patients are classified as axial or peripheral SpA depending on the presence or absence of current back pain, independently of the other disease
Janneke J de Winter, Jacqueline E Paramarta, Henriëtte M de Jong, Marleen G van de Sande, Dominique L Baeten   +4 more
doaj   +1 more source